Bringing a Healthcare Solution to Market – A Life Sciences Hypothetical Panel Discussion

Bartier Perry is proud to host this LESANZ event.

Join us for a hypothetical panel event where we will explore issues commonly encountered when bringing a healthcare solution to market by focussing on a fact scenario specifically tailored for the event. With panel members including experts in life sciences, clinical research, regulatory affairs, market access, patents, law and R&D tax, every angle of this topic will be covered. 

The hypothetical will be moderated by Gavin Stuart, a commercial lawyer and the head of Bartier Perry’s Commercial Disputes team. Gavin has over twenty years’ practicing experience in a broad range of commercial legal work and he has interest areas covering the convergence of law and technology, commercialisation and early stage venture issues, and cross border dealings and disputes.

PANELLISTS

Dennis Feeney is the founder and director of Venture Technology Group and has held executive director and non-executive director functional and governance roles in private affiliates of global companies and public unlisted and listed Australian biotechnology companies.

Steve Gledhill is a qualified Australian, New Zealand, UK and European patent attorney who leads the Sydney biotechnology team of IP boutique FB Rice. 

David Lloyd is the managing director of Southern Star Research which specialises in providing clinical research services for biotechnology, pharmaceutical and medical device clinical trials in Australia and New Zealand.

Dr Dianne Jackson-Matthews is Chief Scientific Officer for the ERA Consulting Group which provides regulatory affairs and product development consulting services. Dianne has over 25 years of experience in pharmaceutical product development, spanning the areas of drugs, biologics, and cell/gene therapies in the US, Europe and Australia, with particular expertise in biotech/biosimilar products. 

Kelly Makarounas-Kirchmann is a principal at KMC Healthcare and a qualified health economist with over 25 years’ experience in the pharmaceutical industry, specialising in the provision of reimbursement of pharmaceuticals in Australia, New Zealand, Asia and Europe.

Rita Chowdhury is an award winning Australian immigration lawyer and is viewed as an expert in employment, business and investment related visas.

Mariana von-Lucken is a tax consultant that specialises in the R&D tax incentive, with over twenty years of experience in tax working with a broad range of clients varying from SMEs to foreign owned subsidiaries.

Matt Kirchmann is a senior director of KMC Healthcare. Matt is a solicitor and economist, having over the last 20 years focused predominantly on the pharmaceutical and health industries.

 

Time

5.45 - 7.30PM

Venue

Bartier Perry - Level 10, 77 Castlereagh Street, Sydney

Cost

LESANZ Members - $45
Non Members - $65